Nutex Health Inc. disclosed non-reliance on its unaudited condensed consolidated financial statements for Q1 2025 and audited consolidated financial statements for 2024 and 2023.
The company determined non-cash adjustments related to the reclassification of obligations from equity to liability.
Preliminary unaudited financial results for Q2 2025 showed significant revenue and profit increases.
Financial Statements Update
Original financial statements should no longer be relied upon due to changes in obligation classification.
Revenue Growth
Revenue increased by 220.7% in Q2 2025 compared to the same period in 2024.
Profit Margin Expansion
Gross profit margin improved to 51.1% in Q2 2025 from 29.7% in Q2 2024.
Cash Collections
The company collected $175 million in cash, the highest amount for any quarter.
Operational Efficiency
Adjusted EBITDA improved significantly to $71.6 million in Q2 2025.
- The financial update indicates a positive trend in revenue growth and profitability for Nutex Health Inc.
- The reclassification of obligations showcases the company's commitment to accurate financial reporting and transparency.
Nutex Health's financial performance in Q2 2025 reflects strong revenue growth and improved profitability despite the need for financial statement corrections.